Trial Profile
Phase 4 Study Comparing Recombinant Follicle Stimulating Hormone (rFSH) or Ultra-pure to HMG in Patients Submitted to IVF Using Gnrh Antagonist
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Follitropin beta (Primary) ; Menotropin
- Indications Female infertility
- Focus Therapeutic Use
- 20 Aug 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 13 Apr 2015 New trial record